<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Int Urol Nephrol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Int Urol Nephrol</journal-id>
      <journal-title-group>
        <journal-title>International Urology and Nephrology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0301-1623</issn>
      <issn pub-type="epub">1573-2584</issn>
      <publisher>
        <publisher-name>Springer Netherlands</publisher-name>
        <publisher-loc>Dordrecht</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22752497</article-id>
      <article-id pub-id-type="pmc">3824272</article-id>
      <article-id pub-id-type="publisher-id">210</article-id>
      <article-id pub-id-type="doi">10.1007/s11255-012-0210-4</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Nephrology - Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Membranoproliferative glomerulonephritis, mantle cell lymphoma infiltration, and acute kidney injury</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lubas</surname>
            <given-names>Arkadiusz</given-names>
          </name>
          <address>
            <phone>+48-22-6817047</phone>
            <fax>+48-22-6816811</fax>
            <email>alubas@wim.mil.pl</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mr&#xF3;z</surname>
            <given-names>Andrzej</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Smoszna</surname>
            <given-names>Jerzy</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Niemczyk</surname>
            <given-names>Stanis&#x142;aw</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Internal Medicine, Nephrology and Dialysotherapy, Military Institute of Medicine, ul. Szaser&#xF3;w 128, 04-141 Warsaw 44, Poland </aff>
        <aff id="Aff2"><label/>Department of Gastroenterology and Hepatology, Medical Center for Postgraduate Education, ul. Roentgena 5, 02-781 Warsaw, Poland </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>1</day>
        <month>7</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>1</day>
        <month>7</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2013</year>
      </pub-date>
      <volume>45</volume>
      <issue>5</issue>
      <fpage>1489</fpage>
      <lpage>1494</lpage>
      <history>
        <date date-type="received">
          <day>6</day>
          <month>12</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>5</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2012</copyright-statement>
      </permissions>
      <abstract id="Abs1">
        <p>Mantle cell lymphoma (MCL) is a rare aggressive lymphoid neoplasm occurring in about 3&#x2013;7&#xA0;% of non-Hodgkin lymphomas in the United States and Europe. Although lymphomas infiltrations are recognized in about half of post-mortem studies, in available literature we found only eight cases of mantle cell lymphoma with renal involvement. Five of them present MCL related glomerulonephritis, two show renal MCL infiltration with acute kidney injury and the last one describes MCL infiltration with acute tubulo-intrerstitial nephritis. We present the first case of a patient with the coexistence of renal mantle cell lymphoma infiltration, subacute membranoproliferative glomerulonephritis and acute kidney injury.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Mantle cell lymphoma</kwd>
        <kwd>Kidney infiltration</kwd>
        <kwd>Glomerulonephritis</kwd>
        <kwd>Acute kidney injury</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media Dordrecht 2013</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Case report</title>
      <p>Patient B.C., age 59, was admitted to the Clinic of Nephrology in August 2011 with a suspected rapidly progressing glomerulonephritis. In an interview, the patient described the existence of eczema present for about 5&#xA0;years, on face, chest, back and limbs recognized as rosacea-like dermatitis. So far performed diagnostics has found markers of eosinophilia increasing since 2008 (0.55&#x2013;2.42&#xA0;g/l) and neck lymphadenopathy (lymph nodes up to 8&#xA0;&#xD7;&#xA0;25&#xA0;mm) without further diagnostics. In 2008, the patient was temporarily treated orally with methylprednisolone and cetirizine. Additional diagnostics performed in June 2010, during another stay at the Clinic of Dermatology, discovered high concentration of total IgE (20.44&#xA0;g/l), slight impairment of renal function (creatinine 106.08&#xA0;&#x3BC;mol/l, GFR-MDRD 67&#xA0;ml/min/1.73&#xA0;m<sup>2</sup>) with proteinuria (0.5&#xA0;g/l) and hematuria (16&#x2013;25/high-power field) suggesting glomerulonephritis, hypercholesterolemia (6.7&#xA0;mmol/l), hyperbilirubinemia (32.8&#xA0;&#x3BC;mol/l) and elevated erythrocyte sedimentation rate (28&#xA0;mm/h). In May 2011, hemorrhagic, Henoch&#x2013;Sch&#xF6;nlein-like purpura of hands, feet and legs joined the existing eczema. For this reason, in July 2011 the patient was hospitalized in the Clinic of Infectious Diseases and Allergology, where persistent features of glomerulonephritis with proteinuria 0.45&#xA0;g/24&#xA0;h, elevated levels of sIgA (8.37&#xA0;g/l), and proper kidney function (creatinine 79.56&#xA0;&#x3BC;mol/l, GFR-MDRD 92&#xA0;ml/min/1.73&#xA0;m<sup>2</sup>) were confirmed. A chest radiograph indicated a widened shadow of the right mediastinum. An ultrasound examination visualized numerous enlarged peripheral lymph nodes in the neck (up to 13&#xA0;&#xD7;&#xA0;37&#xA0;mm), enlarged spleen, and stones of 5&#x2013;9&#xA0;mm in both kidneys. A biopsy of the skin revealed erythema elevatum with neutrophilic, eosinophilic and lymphocytic infiltration around vessels. As a complication of the biopsy, erysipelas of the left upper limb occurred (August 2011), with a fever up to 39&#xA0;&#xB0;C, treated successfully with the second- and third-generation cephalosporins and metronidazole. During the treatment, progressive deterioration of renal function was found. At the admission to the Clinic of Nephrology, the patient did not report any essential ailments. Additional diagnostics revealed signs of progressive multi-organ failure: kidney with nephrotic syndrome (creatinine 772.92&#xA0;&#x3BC;mol/l, GFR-MDRD 7&#xA0;ml/min/1.73&#xA0;m<sup>2</sup>; urea 27.89&#xA0;mmol/l; albumin 25&#xA0;g/l; proteinuria 6.88&#xA0;g/24&#xA0;h with preserved diuresis 2.5&#xA0;l/24&#xA0;h), liver (bilirubin 131.67&#xA0;&#x3BC;mol/l, GGTP 2,938&#xA0;U/l; AST 119&#xA0;U/l, ALT185&#xA0;U/l), and hematopoietic system (Hgb 77&#xA0;g/l) with the complement system activation (C<sub>3</sub> 0.23&#xA0;g/l; C<sub>4</sub> 0.01&#xA0;g/l). The presence of ANA, p- and c-ANCA antibodies was not confirmed, but the level of dsDNA antibodies was elevated up to 44&#xA0;IU/ml. Ultrasound abdomen examination showed enlargement of the kidneys (left kidney length 141&#xA0;mm, right kidney 134&#xA0;mm) with signs of the parenchyma swelling and bilateral kidney stones. Therefore, it was decided to initiate temporary renal replacement therapy by hemodialysis every second day, using a central venous catheter. At the same time, between hemodialysis, immunosuppressive therapy with i.v. infusions of 3&#xA0;&#xD7;&#xA0;1.0&#xA0;g methylprednisolone was started. The treatment continued with oral administration of 60&#xA0;mg prednisone daily. The red blood cell concentrate was transfused. After three hemodialysis interventions, a significant improvement in renal function was achieved, and renal replacement therapy was no longer required (creatinine 114.92&#xA0;&#x3BC;mol/l, GFR-MDRD 60&#xA0;ml/min/1.73&#xA0;m<sup>2</sup>, urea 8.3&#xA0;mmol/l). Moreover, both normalization of liver function (bilirubin 13.68&#xA0;&#x3BC;mol/l, GGTP 772&#xA0;U/l, AST 16&#xA0;U/l, ALT 28&#xA0;U/l) and correction of anemia (Hgb 101&#xA0;g/l) were achieved. A biopsy of the left kidney and a cervical lymph node was collected for histopathological evaluation. Based on the preliminary result of the renal biopsy, in which active lesions were found in the form of vascular loops necrosis and cellular crescents, intravenous infusion of 1.0&#xA0;g of cyclophosphamide was administered.</p>
      <p>Renal core biopsy submitted for embedding contained 10 glomeruli and cortex parenchyma. On histological examination, several foci of dense lymphocytic infiltration were found. These foci concentrated mainly around glomeruli and consisted of medium-sized slightly atypic lymphocytes with sparse cytoplasm. The nuclei were of similar size and cytological features and stayed in close intimacy with each other without overt molding (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Immunohistochemical studies revealed expression of CD20, CD5 and cyclin D1 markers, while CD3 staining was positive only in non-neoplastic cells (Figs.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>, <xref rid="Fig3" ref-type="fig">3</xref>). The Ki-67 staining displayed a low mitotic activity with the expression in about 20&#xA0;% nuclei (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>). These morphology and immunoprofile justified the diagnosis of mantle cell lymphoma invading renal parenchyma. In addition, the biopsy showed features of membranoproliferative glomerulonephritis including mesangial proliferation and basal membranes thickening and double contouring (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). Segmental, cellular crescents were present in 2 of 10 glomeruli as signs of glomerular sclerosis were present in several glomeruli. A striking feature of Bowman&#x2019;s capsule thickening mainly in glomeruli encircled by lymphoma infiltrations was clearly visible. Immunofluorescnece staining showed C<sub>3</sub> deposits in the subendothelial capillary space. In addition, only sparse mononuclear inflammatory infiltration was present within renal parenchyma as well as slight tubular injury in the form of epithelial cell edema and degeneration. The cervical lymph node biopsy confirmed the diagnosis with the recognition of mantle cell lymphoma.<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Mantle cell lymphoma infiltration in renal cortex (HE, <bold>a</bold> &#xD7;100, <bold>b</bold> &#xD7;200)</p></caption><graphic xlink:href="11255_2012_210_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Expression of CD20 (<bold>a</bold> &#xD7;100) and CD3 (<bold>b</bold> &#xD7;100)</p></caption><graphic xlink:href="11255_2012_210_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Expression of cyclin D1 (<bold>a</bold> &#xD7;100) and CD5 (<bold>b</bold> &#xD7;200)</p></caption><graphic xlink:href="11255_2012_210_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>Expression of Ki-67 in about 20&#xA0;% of nuclei (&#xD7;100)</p></caption><graphic xlink:href="11255_2012_210_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>Double contouring of basal membranes and segmental sclerosis of glomerulus (&#xD7;400)</p></caption><graphic xlink:href="11255_2012_210_Fig5_HTML" id="MO5"/></fig></p>
      <p>The tests performed 3&#xA0;weeks after leaving the hospital showed further improvement in renal function, only small-degree proteinuria with disappearance of parenchymal edema in ultrasound imaging (left kidney length 119&#xA0;mm and right kidney 115&#xA0;mm). Significant changes in clinical and biochemical outcomes 3&#xA0;weeks after initial therapy are presented in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>. Patient was transferred to the Clinic of Hematology, in order to continue treatment.<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Significant changes in clinical and biochemical outcomes 3&#xA0;weeks after initial therapy</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Before therapy</th><th align="left">After initial therapy</th></tr></thead><tbody><tr><td align="left">Skin</td><td align="left">Hemorrhagic, Henoch&#x2013;Sch&#xF6;nlein-like purpura</td><td align="left">Slight (retracting) rosacea-like dermatitis</td></tr><tr><td align="left" colspan="3">Kidney</td></tr><tr><td align="left" rowspan="2">&#xA0;Function</td><td align="left">Acute kidney injury (creatinine 772.92&#xA0;&#x3BC;mol/l, GFR-MDRD 7&#xA0;ml/min/1.73&#xA0;m<sup>2</sup>)</td><td align="left">Proper kidney function (creatinine 79.56&#xA0;&#x3BC;mol/l, GFR-MDRD 92&#xA0;ml/min/1.73&#xA0;m<sup>2</sup>)</td></tr><tr><td align="left">Nephrotic syndrome (proteinuria of 6.88&#xA0;g/24&#xA0;h)</td><td align="left">Small-degree proteinuria in spot morning urine sample (0.25&#xA0;g/l)</td></tr><tr><td align="left" rowspan="2">&#xA0;Ultrasound imaging</td><td align="left">Enlargement (left kidney&#x2014;141&#xA0;mm; right kidney&#x2014;134&#xA0;mm)</td><td align="left">Correct length of kidneys (left kidney&#x2014;119&#xA0;mm; right kidney&#x2014;115&#xA0;mm)</td></tr><tr><td align="left">Parenchymal edema</td><td align="left">No abnormal alterations</td></tr><tr><td align="left" colspan="3">Liver</td></tr><tr><td align="left">&#xA0;Function</td><td align="left">Acute liver injury (bilirubin 131.67&#xA0;&#x3BC;mol/l, GGTP 2,938&#xA0;U/l; AST 119&#xA0;U/l, ALT 185&#xA0;U/l)</td><td align="left">Normalization (bilirubin 22.23&#xA0;&#x3BC;mol/l; AST 19&#xA0;U/l, ALT 31&#xA0;U/l)</td></tr><tr><td align="left">&#xA0;Ultrasound imaging</td><td align="left">Hepatomegaly (length: 160&#xA0;mm)</td><td align="left">Hepatomegaly (length: 167&#xA0;mm)</td></tr><tr><td align="left" colspan="3">Spleen</td></tr><tr><td align="left">&#xA0;Ultrasound imaging</td><td align="left">Splenomegaly (length: 137&#xA0;mm)</td><td align="left">Almost normal spleen length (126&#xA0;mm)</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec2" sec-type="discussion">
      <title>Discussion</title>
      <p>Mantle cell lymphoma (MCL) is a rare aggressive lymphoid neoplasm occurring in about 3&#x2013;7&#xA0;% of non-Hodgkin (NHL) lymphomas in United States and Europe [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Most frequent NHL infiltrating kidneys are recognized as extranodal cancers of marginal zone, especially MALT (mucose-associated lymphoid tissue lymphoma), DLBCL (diffuse large B-cell lymphoma) and Burkitt&#x2019;s lymphomas [<xref ref-type="bibr" rid="CR10">10</xref>]. Seizure of the genitourinary tract by lymphoma occurs rarely, its incidence is estimated in about 5&#xA0;%, in which renal involvement is most common and occurs in approximately 37&#xA0;% of cases. On the basis of retrospective studies, Da&#x2019;as et al. [<xref ref-type="bibr" rid="CR3">3</xref>] found that NHL were a rare cause of acute renal failure (9.5&#xA0;%). Ultrasonographic findings are expressed as kidneys enlargement with a decreased echogenicity of the parenchyma.</p>
      <p>Glomerulonephritis (GN), in the course of NHL is one of the causes of acute kidney injury (AKI). In most cases, membranoproliferative GN, mesangial proliferative GN, crescenic GN or minimal change GN, as well as membranous GN and IgA nephropathy are recognized, and clinically expressed as nephrotic syndrome with microhematuria, seldom with reduced complement components or cryoglobulinemia [<xref ref-type="bibr" rid="CR3">3</xref>]. Start of chemotherapy, resulting in partial remission of NHL, correlates with the decrease in the signs of GN and improved organ function [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Infiltration of renal parenchyma by lymphoma cells is very rare and is rated in about 1&#xA0;% of cases [<xref ref-type="bibr" rid="CR3">3</xref>]. Most often, renal lymphoid infiltration is asymptomatic, but sometimes it can be a cause of acute tubulo-interstitial nephritis. Start of immunosuppressive treatment with a few 0.5&#x2013;1.0&#xA0;g intravenous doses of methylprednisolone administered every 1&#x2013;2&#xA0;days, then continued with oral prednisone, enables rapid improvement of renal function, although temporal renal replacement therapy is at times necessary [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. So far, eight cases of kidney impairment due to MCL have been described: four of them presenting proliferative GN, one focal segmental glomerulosclerosis (FSGS), two renal MCL infiltration with AKI, and the last AKI due to acute tubulo-interstitial nephritis [<xref ref-type="bibr" rid="CR3">3</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref>]. The presented case is the first announcement describing the coexistence of renal infiltration by MCL with secondary membranoproliferative subacute GN and AKI. There is no clear explanation of the cause of the patient&#x2019;s AKI. Renal failure occurred in the period of acute dermatitis and suggests diagnosis of post-infectious GN. Whereas participation of skin infection in the development of AKI may be important, the existence of chronic GN (at least from 2008) recognized in the interview seems to be more essential. The changes discovered in the renal biopsy showed a secondary GN with an indication of neoplastic process as the cause of the disease. On the other hand, untreated infiltration of the kidney with MCL could be the reason for their tubulo-interstitial inflammation and AKI [<xref ref-type="bibr" rid="CR7">7</xref>]. Although renal biopsy showed only sparse mononuclear inflammatory infiltration within renal parenchyma and slight tubular injury, the examination took place 10&#xA0;days after starting intravenous methylprednisolone and already achieved the returning of renal function (creatinine 97.24&#xA0;&#x3BC;mol/l). Also, an improvement in renal function after infusions of methylprednisolone does not indicate clearly the cause of AKI with preserved diuresis. Such treatment is recommended as a part of the induction in rapidly progressing GN, acute glomerulopathies, as well as acute tubulo-interstitial renal inflammations. In the presented case, renal biopsy was performed after the improvement of renal function in order to determine diagnosis and further treatment. The diagnosis of MCL renal involvement and neoplastic generalization confirmed later in a lymph node biopsy has become the reason for systemic chemotherapy in the Clinic of Hematology.</p>
    </sec>
    <sec id="Sec3">
      <title>Summary</title>
      <p>The presented case demonstrates for the first time the possibility of renal infiltration by MCL concomitant with secondary membranoproliferative GN. It also shows the importance of the renal biopsy as a useful diagnostic tool in case of kidney impairment due to the lymphoma.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Open Access</title>
      <p>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004</article-title>
          <source>Cancer</source>
          <year>2008</year>
          <volume>113</volume>
          <fpage>791</fpage>
          <lpage>798</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.23608</pub-id>
          <pub-id pub-id-type="pmid">18615506</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sant</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Allemani</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tereanu</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project</article-title>
          <source>Blood</source>
          <year>2010</year>
          <volume>116</volume>
          <fpage>3724</fpage>
          <lpage>3734</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2010-05-282632</pub-id>
          <pub-id pub-id-type="pmid">20664057</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Da&#x2019;as</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Polliack</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Kidney involvement and renal manifestations in non-Hodgkin&#x2019;s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients</article-title>
          <source>Eur J Haematol</source>
          <year>2001</year>
          <volume>67</volume>
          <fpage>158</fpage>
          <lpage>164</lpage>
          <pub-id pub-id-type="doi">10.1034/j.1600-0609.2001.5790493.x</pub-id>
          <pub-id pub-id-type="pmid">11737248</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rerolle</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Thervet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Beaufils</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Crescentic glomerulonephritis and centrocytic lymphoma</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>1999</year>
          <volume>14</volume>
          <fpage>1744</fpage>
          <lpage>1745</lpage>
          <pub-id pub-id-type="doi">10.1093/ndt/14.7.1744</pub-id>
          <pub-id pub-id-type="pmid">10435886</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karim</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pillai</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proliferative glomerulonephritis associated with mantle cell lymphoma&#x2014;natural history and effect of treatment in 2 cases</article-title>
          <source>Clin Nephrol</source>
          <year>2004</year>
          <volume>61</volume>
          <fpage>422</fpage>
          <lpage>428</lpage>
          <pub-id pub-id-type="doi">10.5414/CNP61422</pub-id>
          <pub-id pub-id-type="pmid">15224806</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davies</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Healey</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>KM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute renal failure due to mantle cell lymphoma&#x2014;a case report and discussion of the literature</article-title>
          <source>Clin Nephrol</source>
          <year>2007</year>
          <volume>67</volume>
          <fpage>394</fpage>
          <lpage>396</lpage>
          <pub-id pub-id-type="doi">10.5414/CNP67394</pub-id>
          <pub-id pub-id-type="pmid">17598376</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colak</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Dede</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Canbakan</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute tubulo-interstitial nephritis associated with mantle cell lymphoma presented as acute renal failure</article-title>
          <source>Nephrology</source>
          <year>2007</year>
          <volume>12</volume>
          <fpage>107</fpage>
          <lpage>108</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1797.2006.00758.x</pub-id>
          <pub-id pub-id-type="pmid">17295670</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Mohteshamzadeh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Arsalanizadeh</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Successful treatment of focal segmental glomerulosclerosis in association with mantle cell lymphoma</article-title>
          <source>Ren Fail</source>
          <year>2007</year>
          <volume>29</volume>
          <fpage>363</fpage>
          <lpage>366</lpage>
          <pub-id pub-id-type="doi">10.1080/08860220601166636</pub-id>
          <pub-id pub-id-type="pmid">17497453</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sellin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Friedl</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute renal failure due to a malignant lymphoma infiltration uncovered by renal biopsy</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2004</year>
          <volume>19</volume>
          <fpage>2657</fpage>
          <lpage>2660</lpage>
          <pub-id pub-id-type="doi">10.1093/ndt/gfh201</pub-id>
          <pub-id pub-id-type="pmid">15388825</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schniederjan</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Osunkoya</surname>
              <given-names>AO</given-names>
            </name>
          </person-group>
          <article-title>Lymphoid neoplasms of the urinary tract and male genital organs: a clinicopathological study of 40 cases</article-title>
          <source>Mod Pathol</source>
          <year>2009</year>
          <volume>22</volume>
          <fpage>1057</fpage>
          <lpage>1065</lpage>
          <pub-id pub-id-type="doi">10.1038/modpathol.2009.65</pub-id>
          <pub-id pub-id-type="pmid">19377442</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
